Substance Use Disorders

sec_arr References


  1. Diagnostic and Statistical Manual of Mental Disorders – 5. Washington, DC: American Psychiatric Association; 2013.
  2. Diagnostic and Statistical Manual of Mental Disorders. 4th edText Revision. Washington, DC: American Psychiatric Association; 2000.
  3. Carlton O, Cook CCH. Alcohol and drug misuse. In: Palmer KT, Cox RAF, Brown I, eds. Fitness for Work: The Medical Aspects. 4th ed. New York, NY: Oxford University Press; 2007:chap 24.
  4. Rom WN, Markowitz SB, eds. Environmental and Occupational Medicine. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2007:846.
  5. Gossop M, Green L, Phillips G. Lapse, relapse and survival among opiate addicts after treatment: a prospective follow-up. Brit J Psychiatry. 1989;154, 348-353.
  6. Gillin JC, Smith TL, Irwin M, Butters N, Demodena A, Schuckit Ml. Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry. 1994;51(3):189-97.
  7. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Amer Psychologist. 1992;47,1102-14.
  8. Hunt WA, Barnett LW, Branch LG. Relapse rates in addiction programs. J Clinical Psychol. 1971;27(4):455-4.
  9. American Society of Addiction Medicine. Public Policy Statement on the Definition of Addiction. Adopted 2011.
  10. Sussman S, Sussman AN. Considering the definition of addiction. Int J Environ Res Public Health. 2011,8;4025-38.
  11. Norko MA, Fitch WL. DSM-5 and Substance Use Disorders: Clinicolegal Implications. J Am Acad Psychiatry Law. 2014;42:443-52.
  12. Hasin DS, O’Brien CP, Auriacombe M, et al. DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale. Am J Psychiatry. 2013;170(8):834-51.
  13. Robinson SM, Bryon Adinoff B. The classification of substance of use disorders: historical, contextual, and conceptual considerations. Behav Sci. 2016;6:18.
  14. Gold LH, Anfang SA, Drukteinis AM, et al. AAPL practice guideline for the forensic evaluation of psychiatric disability. J Am Acad Psychiatry Law. 2008;36(4 Suppl):S3-S50.
  15. Canadian Medical Association. Determining Medical Fitness to Operate Motor Vehicles: CMA Driver’s Guide. 7th ed. Ottawa, Ontario: CMA; 2006. Available at
  16. Hartenbaum N. The DOT Medical Examination: A Guide to Commercial Drivers’ Medical Certification. 5th ed. Beverly Farms, Mass: OEM Press; 2007.
  17. Railway Association of Canada. Canadian Railway Medical Rules Handbook. Ottawa, Ontario: RAC; 2011.
  18. Federal Aviation Administration. Guide for Aviation Medical Examiners. Available at
  19. Kennedy CH, Jones DE, Grayson R. Substance abuse services and gambling treatment in the military. In: Kennedy CH, Zillner EA, eds. Military Psychology: Clinical and Operational Applications. New York, NY: Guildford Press; 2006:163.
  20. Gershon RR, Lin S, Li X. Work stress in aging police officers. J Occup Environ Med. 2002;44(2):160-7.
  21. Davey JD, Obst PL, Sheehan MC. Developing a profile of alcohol consumption patterns of police officers in a large scale sample of an Australian police service. Eur Addict Res. 2000;6(4):205-12.
  22. Ballenger JF, Best SR, Metzler TJ, et al. Patterns and predictors of alcohol use in male and female urban police officers. Am J Addict. 2010;20(1):21-9.
  23. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155-60.
  24. Helping Patients Who Drink Too Much: A Clinician’s Guide. 2005 ed. HHS/NIH Publ. No. 07-3769. National Institute on Alcohol Abuse and Alcoholism.
  25. Ries RK, Fiellin DA, Miller SC, Saitz R. Principles of Addiction Medicine. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2009.
  26. Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N. Acute and chronic effects of cannabinoids on human cognition: a systematic review. Biol Psychiatry.2016;79(7):557-67.
  27. Leirer VO, Yesavage JA, Morrow DG. Marijuana carry-over effects on aircraft pilot performance. Aviat Space Environ Med. 1991;62(3):221-7.
  28. Bolla KI, Rothman R, Cadet JL. Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci. 1999;11(3):361-9.
  29. Morgan PT, Pace-Schott EF, Sahul ZH, Coric V, Stickgold R, Malison RT. Sleep architecture, cocaine and visual learning. Addiction. 2008; 103:1344-52.
  30. Brick J, ed. Handbook of the Medical Consequences of Alcohol and Drug Abuse. Binghampton, NY: Haworth Press; 2004:269.
  31. Rapeli P, Kivisaari R, Autti T, et al. Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry. 2006;6:9.
  32. Volkow ND, McLellan AT. Opioid abuse in chronic pain—misconceptions and mitigation strategies. N Engl J Med. 2016;374:1253-63. Available at:
  33. Kronenberg HM. Williams Textbook of Endocrinology. 11th ed. Waltham, Mass: B. Saunders; 2008.
  34. Brower, KJ, Blow FC, Young JP, Hill EM. Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict. 1991;86(6):759-68.
  35. Rogers R, ed. Clinical Assessment of Malingering and Deception. 3rd ed. New York, NY: Guilford Press; 2008:88.
  36. Othmer E, Othmer SC. The Clinical Interview Using the DSM-IV-TR. Volume 1: Fundamentals. Washington, DC: American Psychiatric Publishing; 2002:368.
  37. Morse RM, Flavin DK (for the Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism). The definition of alcoholism. JAMA. 1992;268(8):1012-4.
  38. Rinn W, Desai N, Rosenblatt H, Gastfriend DR. Addiction denial and cognitive dysfunction: a preliminary investigation. J Neuropsychiatry Clin Neurosci. 2002;14(1):52-7.
  39. Talmage JB, Melhorn JM, eds. A Physician’s Guide to Return to Work. Chicago, Ill: American Medical Association Press; 2005:319.
  40. American Psychiatric Association. Quick Reference to the American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium. 2006:89.
  41. Schuckit MA. Alcohol-use disorders. Lancet. 2009;373(9662):492-501.
  42. Krishnamoorthy S, Lip GY, Lane DA. Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review. Am J Med. 2009;122(9):851-6.
  43. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511-8.
  44. Finney JW, Hahn AC, Moos RH. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction. 1996;91(12):1773-96.
  45. American Society of Addiction Medicine. The ASAM Criteria: Treatment Criteria for Addictive, Substance-related, and co-occurring Conditions. Mee-Lee D, Shulman GD, Fishman MJ, Gastfriend DR, Mille MM, eds. Carson City: The Change Companies. 2013.
  46. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689-95.
  47. Domino KB, Hornbein TF, Polissar NL, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA. 2005;293(12):1453-60.
  48. Bottlender M, Soyka M. Outpatient alcoholism treatment: predictors of outcome after 3 years. Drug Alcohol Depend. 2005;80(1):83-9.
  49. Curran GM, Flynn HA, Kirchner J, Booth BM. Depression after alcohol treatment as a risk factor for relapse among male veterans. J Subst Abuse Treat. 2000;19(3):259-65.
  50. Kushner MG, Abrams K, Thuras P, Hanson KL, Brekke M, Sletten S. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcohol Clin Exp Res. 2005;29(8):1432-43.
  51. Kryger MH, Roth T, Dement WC. Principles and Practice of Sleep Medicine. 4th ed. B. Saunders: 1350.
  52. Moselhy HF, Georgiou G, Kahn A. Frontal lobe changes in alcoholism: a review of the literature. Alcohol Alcohol. 2001;36(5):357-68.
  53. Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol. 2009;17(5):337-44.
  54. American Medical Association. Guides to the Evaluation of Permanent Impairment, 5th ed. Cocchiarella L, Andersson GBJ, eds. Chicago, Il: AMA; 2001:362.